Cellectar Biosciences (NASDAQ:CLRB) Now Covered by Analysts at StockNews.com
Stock analysts at StockNews.com assumed coverage on shares of Cellectar Biosciences (NASDAQ:CLRB – Get Free Report) in a ...
PTC Therapeutics (NASDAQ:PTCT) Given Overweight Rating at Morgan Stanley
Morgan Stanley restated their overweight rating on shares of PTC Therapeutics (NASDAQ:PTCT – Free Report) in a research note issued to investors on Friday,Benzinga reports. They currently have a ...
Why Avantor, Inc. (AVTR) Is Plunging So Far In 2025
We recently published an article titled Why These 15 Large-Cap Stocks Are Plunging So Far In 2025. In this article, we are ...
Stevanato: Ramping Syringe Demand, Buy Confirmed
Stevanato's 2024 revenue hits €1.1B, driven by biopharma growth! Discover how facility expansions & rising demand are transforming their market impact.